| Code | 0237C | ||||||
| MA number | 94/0486/12-S | ||||||
| Product Form: | tbl eff 20x50 mg (vre.laminát/Al/papier) | ||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||
| Type of procedure: | National | ||||||
| MAH, country: | Krewel Meuselbach GmbH, Germany | ||||||
| Therapeutic Class: | 94 - FYTOPHARMACA | ||||||
| ATC: |
|
||||||
| Shelf life: | 36 | ||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 15.11.2012 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Hedelix sumive tablety proti kaslu_10/2019.doc
|
| PIL: |
PIL_Hedelix sumive tablety proti kaslu_10/2019.doc
|
| Safety feature | No |
| Data update: | 04.11.2019 |
